A male and female couple in their 60s hugging by the sea
Explore

Non-endoscopic diagnostics for GI care

We are a leading gastrointestinal health company transforming access to digestive health for everyone, everywhere.
Explore
Impact

Earlier matters

Upper GI diseases and cancers affect millions of people globally, every year. With our non-endoscopic diagnostic platform, we are transforming care for digestive diseases by ensuring earlier detection and improving access.

1 in 10

people suffer from upper GI diseases
A photo of the EndoSign cell collection device
EndoSign® is a fast and simple test to protect esophageal health by detecting and monitoring for signs of pre-cancer and other diseases.
Find out more:
Patients
Practitioners
Research

Recent news

View All
11
April 2024
Cyted Health Appoints Betsy Hanna US President
Read more
No items found.
09
April 2024
Capsule sponge test transforms care pathways in Scotland
Read more
No items found.
15
March 2024
Cyted and Microsoft Research Collaboration Published in Nature Communications
Read more
No items found.

In partnership with

Cyted is proud to collaborate with a network of esteemed partners and investors who share our vision for innovative healthcare solutions.
A couple in their 60's hugging at home
Get in touch for more information about our early cancer test and data-driven diagnostics.
Get in touch